文献速递艾滋病与性传播感染

新型冠状病毒肺炎大流行对撒哈拉以南非洲11国人类免疫缺陷病毒服务的影响

Effects of the Coronavirus Disease 2019 Pandemic on Human Immunodeficiency Virus Services: Findings from 11 Sub-Saharan African Countries.
PubMed 文献 · Clin Infect Dis · 2022-01-01

分析撒哈拉以南非洲11国1059家卫生机构2019年10月至2020年9月的季度数据,按防疫措施严格程度分组进行双重差分评估。结果显示HIV检测、新启动抗逆转录病毒治疗在疫情初期下降后迅速反弹,在治人数、病毒载量检测及抑制率整体上升,体现HIV项目在新冠疫情危机中的韧性。

要点

  • HIV检测数从Q2的572845降至Q3的553780,降幅3.3%,Q4回升至612646,增幅10.6%。
  • 新启动抗逆转录病毒治疗从Q2至Q3下降9.8%,Q4回升9.8%。
  • 在治人数从Q1的419028增至Q4的476010,病毒载量抑制率从87.5%升至90.1%。

核心结论

  • 疫情初期下降后迅速反弹,HIV检测、新启动或在治抗逆转录病毒治疗、病毒载量检测及抑制率在整个期间均增加,显示HIV项目在新冠疫情危机中具有韧性。

研究设计与样本

  • 分析撒哈拉以南非洲11国1059家卫生机构2019年10月至2020年9月的季度数据,并按防疫措施严格程度分类。
  • 采用双重差分评估,比较严格程度较高与较低组从Q1-Q2到Q3-Q4的HIV服务变化。

主要发现

  • HIV检测数从Q2的572845降至Q3的553780(降幅3.3%),HIV阳性检出数从Q2至Q3下降4.9%。
  • HIV检测数从Q3的553780增至Q4的612646(增幅10.6%),HIV阳性检出数增加8.8%至23457,阳性检出率相近(3.8%)。
  • 新启动抗逆转录病毒治疗从Q2至Q3下降9.8%,Q4增加9.8%。
  • 在治人数从Q1的419028增至Q4的476010,过去12个月内接受病毒载量检测的人数从Q1的255290增至Q4的312869。
  • 病毒载量抑制率未见下降,从Q1的87.5%升至Q4的90.1%;HIV检测(P < .0001)和新启动抗逆转录病毒治疗(P = .001)与严格程度呈负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Due to concerns about the effects of the coronavirus disease 2019 (COVID-19 pandemic on health services, we examined its effects on human immunodeficiency virus (HIV) services in sub-Saharan Africa. METHODS: Quarterly data (Q1, 10/2019-12/2019; Q2, 1/2020-3/2020; Q3, 4/2020-6/2020; Q4, 7/2020-9/2020) from 1059 health facilities in 11 countries were analyzed and categorized by stringency of pandemic measures. We conducted a difference-in-differences assessment of HIV service changes from Q1-Q2 to Q3-Q4 by higher vs lower stringency. RESULTS: There was a 3.3% decrease in the number HIV tested from Q2 to Q3 (572 845 to 553 780), with the number testing HIV-positive declining by 4.9% from Q2 to Q3. From Q3 to Q4, the number tested increased by 10.6% (612 646), with an increase of 8.8% (23 457) in the number testing HIV-positive with similar yield (3.8%). New antiretroviral therapy (ART) initiations declined by 9.8% from Q2 to Q3 but increased in Q4 by 9.8%. Across all quarters, the number on ART increased (Q1, 419 028 to Q4, 476 010). The number receiving viral load (VL) testing in the prior 12 months increased (Q1, 255 290 to Q4, 312 869). No decrease was noted in VL suppression (Q1, 87.5% to Q4, 90.1%). HIV testing (P < .0001) and new ART initiations (P = .001) were inversely associated with stringency. CONCLUSIONS: After initial declines, rebound was brisk, with increases noted in the number HIV tested, newly initiated or currently on ART, VL testing, and VL suppression throughout the period, demonstrating HIV program resilience in the face of the COVID-19 crisis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Harris TG, Jaszi E, Lamb MR, et al. Effects of the Coronavirus Disease 2019 Pandemic on Human Immunodeficiency Virus Services: Findings from 11 Sub-Saharan African Countries. Clin Infect Dis. 2022. PMID: 34791096. doi:10.1093/cid/ciab951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。